Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1066, doi. 10.20892/j.issn.2095-3941.2021.0040
- By:
- Publication type:
- Article
Works matching IS 14622815 AND DT 2021 AND VI 94 AND IP 6
Results: 20
1
2
Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1118, doi. 10.20892/j.issn.2095-3941.2021.0052
- By:
- Publication type:
- Article
3
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1109, doi. 10.20892/j.issn.2095-3941.2021.0037
- By:
- Publication type:
- Article
4
Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1092, doi. 10.20892/j.issn.2095-3941.2020.0278
- By:
- Publication type:
- Article
5
Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1080, doi. 10.20892/j.issn.2095-3941.2020.0351
- By:
- Publication type:
- Article
6
The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1134, doi. 10.20892/j.issn.2095-3941.2021.0023
- By:
- Publication type:
- Article
7
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1053, doi. 10.20892/j.issn.2095-3941.2021.0022
- By:
- Publication type:
- Article
8
The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1040, doi. 10.20892/j.issn.2095-3941.2020.0450
- By:
- Publication type:
- Article
9
EZH2 identifies the precursors of human natural killer cells with trained immunity.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1021, doi. 10.20892/j.issn.2095-3941.2020.0791
- By:
- Publication type:
- Article
10
Cyclophosphamide abrogates the expansion of CD4<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 1010, doi. 10.20892/j.issn.2095-3941.2021.0027
- By:
- Publication type:
- Article
11
Targeting myeloid-derived suppressor cells for cancer therapy.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 992, doi. 10.20892/j.issn.2095-3941.2020.0806
- By:
- Publication type:
- Article
12
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 981, doi. 10.20892/j.issn.2095-3941.2021.0029
- By:
- Publication type:
- Article
13
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 966, doi. 10.20892/j.issn.2095-3941.2020.0801
- By:
- Publication type:
- Article
14
Personalized immunotherapy in cancer precision medicine.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 955, doi. 10.20892/j.issn.2095-3941.2021.0032
- By:
- Publication type:
- Article
15
Multiplex imaging reveals the architecture of the tumor immune microenvironment.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
16
Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
17
The role of DLL1 in long-term vascular normalization and cancer immunotherapy.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 940, doi. 10.20892/j.issn.2095-3941.2021.0507
- By:
- Publication type:
- Article
18
Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
19
Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
20
Cancer immunology and immunotherapy.
- Published in:
- Community Practitioner, 2021, v. 94, n. 6, p. 931, doi. 10.20892/j.issn.2095-3941.2021.0036
- By:
- Publication type:
- Article